19-38523042-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP2
The NM_000540.3(RYR1):c.10274C>T(p.Thr3425Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,602,230 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000540.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151974Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000118 AC: 27AN: 229004Hom.: 0 AF XY: 0.000120 AC XY: 15AN XY: 124720
GnomAD4 exome AF: 0.000139 AC: 201AN: 1450138Hom.: 0 Cov.: 33 AF XY: 0.000144 AC XY: 104AN XY: 720624
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152092Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74354
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
- -
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Inborn genetic diseases Uncertain:1
The c.10274C>T (p.T3425M) alteration is located in exon 68 (coding exon 68) of the RYR1 gene. This alteration results from a C to T substitution at nucleotide position 10274, causing the threonine (T) at amino acid position 3425 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
RYR1-related myopathy Uncertain:1
A heterozygous missense variant was identified, NM_000540.2(RYR1):c.10274C>T in exon 68 of 106 of the RYR1 gene. This substitution is predicted to create a moderate amino acid change from a threonine to a methionine at position 3425 of the protein; NP_000531.2(RYR1):p.(Thr3425Met). The threonine at this position has low conservation (100 vertebrates, UCSC), and is not situated in a known functional domain. In silico software predictions of the pathogenicity of this variant are conflicting (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD database at a global population frequency of 0.012% (27 heterozygotes, 0 homozygotes) with a South Asian sub-population frequency of 0.048%. Two alternative residue changes at the same location have been reported in the gnomAD database at a frequency of 0.015% and 0.0026%. This variant has been previously reported as a VUS in patient with RYR1-related disorder (ClinVar). Based on information available at the time of curation, this variant has been classified as a VUS. -
Central core myopathy Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
RYR1-related disorder Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at